Non-Small Cell Lung Carcinoma
Also known as: Non-Small Cell Lung Cancer (NSCLC) / NSCLC / Non-small Cell Lung Cancers / NSCLC (Non-Small Cell Lung Cancer) / Non-Small Cell Lung Cancer / Lung Cancer (Non-Small Cell) / Lung Cancer (NSCLC) / NSCLC (Non-small Cell Lung Carcinoma) / Non Small Cell Carcinoma of the Lung / Non-small Cell Lung Carcinoma (Adenocarcinoma) / Non-Small Cell Lung Carcinoma (NSCLC) / Non-small cell lung cancer (disorder) / Non-small cell lung cancer NOS / Carcinoma, Non-Small-Cell Lung
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB11595 | Atezolizumab | A monoclonal antibody used to treat advanced or metastatic urothelial carcinoma with disease progression during or up to 12 months after platinum-containing chemotherapy. |
| DB00445 | Epirubicin | An anthracycline topoisomerase II inhibitor used as an adjuvant to treating axillary node metastases in patients who have undergone surgical resection of primary breast cancer. |
| DB09330 | Osimertinib | A tyrosine kinase inhibitor used in the treatment of certain types of non-small cell lung carcinoma. |